<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34090521</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">2053-8871</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>8</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cerebellum &amp; ataxias</Title>
          <ISOAbbreviation>Cerebellum Ataxias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years.</ArticleTitle>
        <Pagination>
          <StartPage>14</StartPage>
          <MedlinePgn>14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">14</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s40673-021-00137-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paraneoplastic cerebellar degeneration (PCD) is a classic neurological syndrome where the presence of Anti-Tr/DNER antibodies is strongly associated with Hodgkin Lymphoma (HL). Awareness of the syndrome is important because with prompt treatment the prognosis of HL is good. The diagnosis can be a challenge in some patients. The importance of PCD in the detection of a cancer relapse is not clarified. We report the case of a 76-year-old man where a PCD, initially misdiagnosed as a stroke led to a diagnosis of a very late relapse of HL after 12 years.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 76-year-old male with a 3-week history of unstable walking, slow speech and dizziness was admitted to our stroke unit apparently because the symptoms started acutely. With a diagnostic delay of 3-4 weeks a correct diagnosis of relapse HL was made based on cerebrospinal fluid changes with a strong positive reaction to anti-Tr/DNER antibodies, FDG-PET/CT scan, and biopsy findings. The medical history revealed that the patient had been diagnosed with HL previously, but has been in complete remission for 12 years. The patient was treated with intravenous immunoglobulin, chemo- and radiation therapy. Over the following 6-8 weeks he improved.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Late relapse in HL is very rare. If it occurs it presents as a symptomatic lymphadenopathy. Our case shows, that PCD can be the only presenting symptom of a very late relapse of HL. Paraneoplastic neurological syndromes (PNS) should be considered even in patients with very long cancer remission. PCD can in rare cases mimic a stroke within the posterior circulation. If MR imaging in severe acute/subacute cerebellar syndrome is normal further investigation is mandatory to rule out a PNS, particular in patients with a previous cancer.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Christensen</LastName>
            <ForeName>Peter Broegger</ForeName>
            <Initials>PB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Aalborg University Hospital, Ladegaardsgade 5, 9000, Aalborg, Denmark. p.broegger@rn.dk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gregersen</LastName>
            <ForeName>Henrik</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almasi</LastName>
            <ForeName>Charlotte</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cerebellum Ataxias</MedlineTA>
        <NlmUniqueID>101648460</NlmUniqueID>
        <ISSNLinking>2053-8871</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hodgkin lymphoma</Keyword>
        <Keyword MajorTopicYN="N">cerebellar degeneration</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic syndrome</Keyword>
        <Keyword MajorTopicYN="N">relapse</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34090521</ArticleId>
        <ArticleId IdType="pmc">PMC8180073</ArticleId>
        <ArticleId IdType="doi">10.1186/s40673-021-00137-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s40673-021-00137-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hammack J, Kotanides H, Rosenblum MS, Posner JB. Paraneoplastic cerebellar degeneration: II. Clinical and immunologic findings in 21 patients with Hodgkin´s disease. Neurology. 1992;42:1938–43. doi: 10.1212/WNL.42.10.1938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.42.10.1938</ArticleId>
            <ArticleId IdType="pubmed">1407576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernal F, Shams´ili S, Rojas R, Sanchez-Valle R, Saiz A, Dalmau J, et al.  Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin`s disease. Neurology. 2003;60:230–34. doi: 10.1212/01.WNL.0000041495.87539.98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.WNL.0000041495.87539.98</ArticleId>
            <ArticleId IdType="pubmed">12552036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graus F, Arino H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood. 2014;123(21):3220–38. doi: 10.1182/blood-2014-03-537506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2014-03-537506</ArticleId>
            <ArticleId IdType="pmc">PMC4046430</ArticleId>
            <ArticleId IdType="pubmed">24705493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, et al.  Outcome of very late relapse in patients with Hodgkins´s lymphomas. Adv Hematol. 2011;2011:707542. doi: 10.1155/2011/707542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2011/707542</ArticleId>
            <ArticleId IdType="pmc">PMC3023035</ArticleId>
            <ArticleId IdType="pubmed">21253449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogrig A, Bernardini A, Gigli GL, Corazza E, Marini A, Segati S, et al.  Stroke-like presentation of cerebellar degeneration: a single-center experience and review of the literature. The Cerebellum. 2019;18:976–82. doi: 10.1007/s12311-019-01075-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12311-019-01075-9</ArticleId>
            <ArticleId IdType="pubmed">31463826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ducray F, Graus F, Vigliani MC, Antoine JC, Rogemond V, Saiz A, et al.  Delayed onset of a second paraneoplastic neurological syndrome in eight patients. J Neurol Neurosurg Psychiatry. 2010;81:937–39. doi: 10.1136/jnnp.2009.190199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2009.190199</ArticleId>
            <ArticleId IdType="pubmed">20562403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graus F, Dalmau J, René R, Malats JJ, Verschuuren F, Cardenal N, et al.  J Clin Oncol. 1997;15:2866–72. doi: 10.1200/JCO.1997.15.8.2866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.1997.15.8.2866</ArticleId>
            <ArticleId IdType="pubmed">9256130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Graf E, Maat P, Hulsenboom E, van den Berg R, van de Bent M, Demmers J, et al.  Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815–24. doi: 10.1002/ana.23550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.23550</ArticleId>
            <ArticleId IdType="pubmed">22447725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greene M, Lai Y, Baella N, Dalmau J, Lancaster E. Antibodies to Delta/Notch-like growth factor-related receptor in patients with Anti-Tr, and Hodgkin lymphoma. JAMA Neurol. 2014;71(8):1003–8. doi: 10.1001/jamaneurol.2014.999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2014.999</ArticleId>
            <ArticleId IdType="pmc">PMC4130785</ArticleId>
            <ArticleId IdType="pubmed">24935874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al.  Paraneoplastic cerebellar ataxia due to autoantibodies to a glutamate receptor. N Engl J Med. 2000;342(1):21–7. doi: 10.1056/NEJM200001063420104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200001063420104</ArticleId>
            <ArticleId IdType="pubmed">10620645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine JC, et al.  Antibodies to the metabotropic glutamate receptor 5 in Ophelia syndrome. Neurology. 2011;77:1698–01. doi: 10.1212/WNL.0b013e3182364a44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0b013e3182364a44</ArticleId>
            <ArticleId IdType="pmc">PMC3208954</ArticleId>
            <ArticleId IdType="pubmed">22013185</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
